- Home
- HRTX vs SEVN Comparison
HRTX vs SEVN Comparison
Compare HRTX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRTX | SEVN |
|---|---|---|
| Founded | 1983 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.3M | 187.6M |
| IPO Year | 2007 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HRTX | SEVN |
|---|---|---|
| Price | $0.87 | $8.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.50 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 2.3M | 70.0K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $154,904,000.00 | $29,383,000.00 |
| Revenue This Year | $15.28 | $27.75 |
| Revenue Next Year | $20.29 | $4.06 |
| P/E Ratio | ★ N/A | $44.16 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.74 | $7.90 |
| 52 Week High | $2.30 | $12.85 |
Technical Indicators
Market Signals| Indicator | HRTX | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.36 | 58.55 |
| Support Level | $0.74 | $8.27 |
| Resistance Level | $0.87 | $8.95 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 7.88 | 100.00 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.